Stage IIIA-N2 non-small-cell lung cancer: from 'surprise' involvement to surgical nightmare

被引：11
|
作者：
Van Schil, Paul E. [1 ]
机构：
[1] Univ Antwerp Hosp, Dept Thorac & Vasc Surg, Wilrijkstr 10, B-2650 Antwerp, Belgium
来源：
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 2016年 / 49卷 / 06期
关键词：
Non-small-cell lung cancer; Stage IIIA; Staging; Restaging; Chemoradiation; Surgery; RANDOMIZED CONTROLLED-TRIAL; INDUCTION CHEMOTHERAPY; PHASE-III; RADIOTHERAPY; SURGERY; RESECTION; N2;
D O I：
10.1093/ejcts/ezv457
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1613 / 1614
页数：2
相关论文
共 50 条
  • [1] Generalized or personalized treatment for stage IIIA-N2 non-small-cell lung cancer?
    Vansteenkiste, Johan
    Van Damme, Valerie
    Dooms, Christophe
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1605 - 1609
  • [2] Role of surgery for stage IIIA-N2 non-small cell lung cancer
    Yang, Fan
    Wang, Jun
    THORACIC CANCER, 2011, 2 (03) : 90 - 94
  • [3] Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
    Senan, S.
    Ozguroglu, M.
    Daniel, D.
    Villegas, A.
    Vicente, D.
    Murakami, S.
    Hui, R.
    Faivre-Finn, C.
    Paz-Ares, L.
    Wu, Y. L.
    Mann, H.
    Dennis, P. A.
    Antonia, S. J.
    ESMO OPEN, 2022, 7 (02)
  • [4] Effects of Neoadjuvant Radiotherapy on Survival in Patients with Stage IIIA-N2 Non-Small-Cell Lung Cancer Following Pneumonectomy
    Qu, Chenghao
    Li, Rongyang
    Han, Jingyi
    Yue, Weiming
    Tian, Hui
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [5] Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?
    Pages, P. -B.
    Pforr, A.
    Delpy, J. -P.
    Abou Hanna, H.
    Bernard, A.
    REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (05) : 485 - 492
  • [6] Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer
    Tanaka, F
    Yanagihara, K
    Otake, Y
    Kawano, Y
    Miyahara, R
    Takenaka, K
    Katakura, H
    Ishikawa, S
    Ito, H
    Wada, H
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (06) : 612 - 618
  • [7] Prognostic Factors in Resected Pathologic (p-) Stage IIIA-N2, Non-Small-Cell Lung Cancer
    Fumihiro Tanaka
    Kazuhiro Yanagihara
    Yosuke Otake
    Yozo Kawano
    Ryo Miyahara
    Kazumasa Takenaka
    Hiromichi Katakura
    Shinya Ishikawa
    Harumi Ito
    Hiromi Wada
    Annals of Surgical Oncology, 2004, 11 : 612 - 618
  • [8] Real-World Analysis of Survival and Treatment Efficacy in Stage IIIA-N2 Non-Small Cell Lung Cancer
    Josephides, Eleni
    Dunn, Roberta
    Henry, Annie-Rose
    Pilling, John
    Harrison-Phipps, Karen
    Patel, Akshay
    Ahmad, Shahreen
    Skwarski, Michael
    Spicer, James
    Georgiou, Alexandros
    Ghosh, Sharmistha
    Van Hemelrijck, Mieke
    Karapanagiotou, Eleni
    Smith, Daniel
    Bille, Andrea
    CANCERS, 2024, 16 (17)
  • [9] What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck, Jan P.
    De Pauw, Rebecca
    Tournoy, Kurt
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (02) : 199 - 206
  • [10] Prognostic Value of Tumor Size in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer
    Chen, Chih-Yu
    Wu, Bing-Ru
    Chen, Chia-Hung
    Cheng, Wen-Chien
    Chen, Wei-Chun
    Liao, Wei-Chih
    Chen, Chih-Yi
    Hsia, Te-Chun
    Tu, Chih-Yen
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
12345